Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19

Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can cause acute respiratory distress syndrome, hypercoagulability, hypertension, and multiorgan dysfunction. In recent months, SARS-CoV-2 has gradually spread to more than 200 countries and regions, resulting in more than 500,000 deaths globally.